Table 1

Characteristics and all-cause mortality of end-stage renal disease (ESRD) patients (January 2016 to August 2022)

2016201720182019202020212022*
ESRD population, n109 826126 783136 417141 386141 185130 426134 520
Median age, years65 (56–74)65 (57–74)66 (57–74)66 (57–74)66 (57–74)65 (56–73)65 (56–72)
Age group, n (%)
0–19634 (0.6)770 (0.6)902 (0.7)1081 (0.8)1214 (0.9)1362 (1.0)1486 (1.1)
20–448091 (7.4)9973 (7.9)11 530 (8.5)12 810 (9.1)14 257 (10.1)15 244 (11.7)16 222 (12.1)
45–6438 763 (35.3)45 573 (35.9)50 311 (36.9)54 031 (38.2)56 174 (39.8)54 483 (41.8)56 514 (42.0)
65–7430 961 (28.2)35 330 (27.9)37 646 (27.6)38 545 (27.3)37 772 (26.8)33 589 (25.8)34 530 (25.7)
75 or more31 377 (28.6)35 137 (27.7)36 028 (26.4)34 919 (24.7)31 768 (22.5)25 748 (19.7)25 768 (19.2)
Sex, n (%)
Male48 283 (44.0)56 314 (44.4)61 086 (44.8)64 010 (45.3)64 783 (45.9)60 981 (46.8)63 469 (47.2)
Female61 543 (56.0)70 469 (55.6)75 331 (55.2)77 376 (54.7)76 402 (54.1)69 445 (53.2)71 051 (52.8)
Incident cases, n57 56147 79842 05339 14735 72129 75125 820
Death, n27 64830 84132 41934 17835 92240 51021 726
Mortality rate (% of ESRD population)25.2%24.3%23.8%24.2%25.4%31.1%16.2%
Death by age group, n (%)
0–1982 (0.3)92 (0.3)74 (0.2)90 (0.3)80 (0.2)77 (0.2)49 (0.2)
20–441350 (4.9)1441 (4.7)1507 (4.6)1626 (4.8)1577 (4.4)1949 (4.8)1072 (4.9)
45–648775 (31.7)9656 (31.3)10 082 (31.1)10 547 (30.9)11 194 (31.2)12 912 (31.9)7139 (32.9)
65–747902 (28.6)8698 (28.2)9290 (28.7)9749 (28.5)10 378 (28.9)11 837 (29.2)6338 (29.2)
75 or more9539 (34.5)10 954 (35.5)11 466 (35.4)12 166 (35.6)12 693 (35.3)13 735 (33.9)7128 (32.8)
Death by sex, n (%)
Male12 389 (44.8)13 895 (45.1)14 815 (45.7)15 617 (45.7)16 484 (45.9)18 572 (45.8)9890 (45.5)
Female15 259 (55.2)16 946 (54.9)17 604 (54.3)18 561 (54.3)19 438 (54.1)21 938 (54.2)11 836 (54.5)
  • *Data up to 31 August 2022.